跳转至内容
Merck

Y0001287

肝素 钙盐

European Pharmacopoeia (EP) Reference Standard

别名:

Heparin calcium salt

登录查看公司和协议定价


About This Item

CAS号:
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

heparin

製造商/商標名

EDQM

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-8°C

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Heparin calcium for NMR identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Depression improvement with calcium heparin.
Salvador Sarro Maluquer et al.
General hospital psychiatry, 24(6), 450-451 (2002-12-20)
L Bonnecarrère et al.
Journal des maladies vasculaires, 34(5), 366-371 (2009-09-29)
Subcutis calcinosis, characterized by abnormal calcium deposition in the skin, is a rare side effect of calcium containing heparins. Two patients with renal failure presented skin lesions after receiving a calcium-containing heparin treatment. The first patient exhibited erythematous nodules on
Eosinophilic panniculitis and hypereosinophilia caused by hypersensitivity to calcium heparin.
Masahito Yasuda et al.
European journal of dermatology : EJD, 20(3), 401-402 (2010-04-20)
Claudio Zanon et al.
Tumori, 91(6), 477-480 (2006-02-07)
The evaluation of low-molecular-weight heparin use to prevent arterial and venous thrombosis in patients with indwelling arterial Port-a-Cath implants. From 1996 to March 2003 we placed 370 indwelling hepatic arterial catheters with a minimally invasive approach. The left distal subclavian
M R Caballero et al.
Allergologia et immunopathologia, 31(6), 324-328 (2003-12-13)
Few descriptions of allergic reactions to heparin have been published, because these reactions are not well known, their prevalence is low and they are difficult to diagnose due to the lack of an in vitro test until now. We propose

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门